A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...

Market shrink during COVID, price hikes due to things like increased material costs and property taxes, the uncertainty around tariffs, and a concern that most of the region’s builders are aging out ...

Industry leaders discuss tariffs, AI, workforce challenges, and tech’s role in navigating uncertainty in New Jersey's ...

More than 7 million Americans live with Alzheimer’s disease — the highest number ever, according to a new report. Americans want to know if they have the disease and want medication to treat it if ...